<DOC>
	<DOCNO>NCT00535743</DOCNO>
	<brief_summary>The objective trial explore dose-response relation Org 25969 give reversal agent 3 15 minute follow administration 1.0 1.2 mg/kg Esmeron速 ( rocuronium ) subject ASA 1 3 , evaluate safety single dose Org 25969 administer subject ASA 1 3 .</brief_summary>
	<brief_title>Dose-Finding Trial With Sugammadex 3 15 Minutes After 1.0 1.2 mg/kg Rocuronium Bromide Subjects ASA Class 1-3 ( 19.4.206 ) ( P05944 )</brief_title>
	<detailed_description>In US high dose recommend package insert Zemuron速 ( i.e . trade name Esmeron速 US ) 1.2 mg/kg whereas Europe 1.0 mg/kg . For dos , dose recommendation reversal Org 25969 found . Hence , present trial set explore dose-response relation Org 25969 give reversal agent 3 15 minute follow administration 1.0 1.2 mg/kg Esmeron速 subject ASA 1 3 . The sub-investigator perform subjective safety assessment anesthesia remain blinded .</detailed_description>
	<mesh_term>Rocuronium</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>Subjects ASA class 1 3 , equal age 18 year ; Subjects schedule surgical procedure anticipate duration anesthesia least 120 minute , without need muscle relaxation intubation ; Subjects schedule surgical procedure supine position ; Subjects give write informed consent . Subjects difficult intubation anatomical malformation expect ; Subjects know suspect neuromuscular disorder impair neuromuscular block and/or significant renal dysfunction ; Subjects know suspect ( family ) history malignant hyperthermia ; Subjects know suspect allergy narcotic , muscle relaxant medication use general anesthesia ; Subjects receive medication know interfere neuromuscular block agent , anticonvulsant Mg2+ ; Subjects already participate CT 19.4.206 ; Subjects participate another clinical trial , preapproved NV Organon , within 30 day enter CT 19.4.206 ; Female subject pregnant : female pregnancy exclude medical history hCG test within 24 hour surgery except female childbearing potential , i.e . least 2 year menopausal undergone tubal ligation hysterectomy ; Female subject childbearing potential use follow method birth control ( one month ) : condom diaphragm spermicide , vasectomized partner ( &gt; 6 month ) , IUD , abstinence ; Female subject breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>